

In the News

Citius Pharmaceuticals (NASDAQ:CTXR) And Novellus Therapeutics Enter Exclusive Global Licensing Agreement For Proprietary iMSC Therapy

Oct 15, 2020

Novellus Therapeutics licenses iMSCs to Citius Pharmaceuticals' NoveCite

Oct 14, 2020

Citius Pharma in-licenses cell therapy for COVID-19 and other respiratory conditions

Oct 13, 2020

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Expands Its Intellectual Property Associated With Mino-Wrap To Enhance Its Design

Sep 3, 2020

Citius Pharma -12% after upsizing equity offering to $8.4M

Aug 6, 2020

Citius Pharmaceuticals announces $6M bought deal offering

Aug 5, 2020

Citius Pharmaceuticals names Myron Czuczman, M.D. as Chief Medical Officer

Jul 14, 2020

Citius Pharm regains Nasdaq compliance

Jul 13, 2020

Citius Pharmaceuticals receives FDA response to PIND for iMSCs

Jun 26, 2020

20 Healthcare Stocks Moving In Thursday's Pre-Market Session

Jun 25, 2020